Literature DB >> 24900597

Sphingosine-1-phosphate (S1P) Receptor Modulators Provide Potential for Diverse Treatments.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2013        PMID： 24900597      PMCID： PMC4027373          DOI： 10.1021/ml400360y

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.

Authors:  Roger A Sabbadini
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 2.  Sphingosine-1-phosphate signaling and its role in disease.

Authors:  Michael Maceyka; Kuzhuvelil B Harikumar; Sheldon Milstien; Sarah Spiegel
Journal:  Trends Cell Biol       Date:  2011-10-14       Impact factor: 20.808

Review 3.  Sphingosine 1-phosphate receptor signaling.

Authors:  Hugh Rosen; Pedro J Gonzalez-Cabrera; M Germana Sanna; Steven Brown
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 4.  Novel agents targeting bioactive sphingolipids for the treatment of cancer.

Authors:  A Adan-Gokbulut; M Kartal-Yandim; G Iskender; Y Baran
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye.

Authors:  James S Swaney; Kelli M Moreno; Angela M Gentile; Roger A Sabbadini; Glenn L Stoller
Journal:  Exp Eye Res       Date:  2008-07-18       Impact factor: 3.467
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.